No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH Trial

Summary

Results from the Surgical Treatment of Ischemic Heart Failure STICH trial [NCT00023595] showed no mortality benefit from coronary artery bypass grafting in addition to intensive guideline-based medical therapy compared with medical therapy alone.

  • Heart Failure
  • Interventional Techniques & Devices Clinical Trials
View Full Text